Search

everythinglearnresearchcommunity

for

Search:↓

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Early puberty is more common in girls and African-American children, possibly due to nutrition, obesity, stress, and environmental factors, and is treated with hormone therapy.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Most patients improved with oral contraceptives, but some needed additional treatment.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Removing both ovaries treated the woman's excess male hormone symptoms.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The document explains how male reproductive hormones work and affect the body.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.